| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,697,700 | 2,780,000 | 2,557,100 | 2,945,000 | | Cost of Revenue | 1,923,300 | 2,001,200 | 1,888,000 | 2,128,300 | | | Gross Profit | 774,400 | 778,800 | 669,100 | 816,700 | | | Operating Expenses | | Research Development | 63,800 | 57,300 | 52,900 | 71,800 | | Selling General and Administrative | 609,000 | 393,900 | 384,000 | 440,100 | | Non Recurring | 8,900 | 20,400 | 10,700 | 61,600 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 92,700 | 307,200 | 221,500 | 243,200 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 9,600 | 1,300 | 1,400 | 4,200 | | Earnings Before Interest And Taxes | 102,300 | 308,500 | 222,900 | 247,400 | | Interest Expense | 24,400 | 22,900 | 26,400 | 39,500 | | Income Before Tax | 77,900 | 285,600 | 196,500 | 207,900 | | Income Tax Expense | 11,900 | 83,000 | 10,000 | 32,400 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 66,000 | 202,600 | 186,500 | 175,500 | | | Non-recurring Events | | Discontinued Operations | (7,000) | (1,200) | (2,400) | 10,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 59,000 | 201,400 | 184,100 | 185,500 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $59,000 | $201,400 | $184,100 | $185,500 |
|
0.31% Nasdaq 
Income Statement
